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Abstract
Arms; The present study evaruates the impact of hypoxia rerated carbonic anhydrase rx and
xll isoenzyme expression as a basic adaptive mechanism to neutrarize intracerurar acidosis
in classical Hodgkin,s lymphoma (cHL),
Methods: 87 primary biopsies and r.5 relapsed tissue samples diagnosed with cHL were
analyzed for necrosis, CAIX and CAXII expression and cell proliferation to compare hypoxia
related histological and functional data with survival characteristics.
Resu/ts; Variable, but highly selective cell membrane CAIX expression could be
demonstrated in Hodgkin-Reed_sternberg (HRS) cells in 39/81 samples (48.1%) while
virtually no staining presented in their microenvironment. rn contrast, cAx, expression in
HRS-ce',s courd be demonstrated in onry 18/77 sampres (23.4%) with significant stromar
positivity (50/77, 64.9%).fhe CAtX+ phenotype was strongly associated with lymphocyte
depletion (4/4, tOO%) and nodular sclero sis (29/5I,56,9%) subtypes. CAtX/Ki_67 duat
immunohistochemistry demonstrated suppressed ce, proriferation in cArx+ compared to
cAlx- HRs-cerrs (p<o.oo1). 72 months progression free survivar (pFs) was significantry rower
for the CA|X+ group (0.192) compared with the CAtX- group (0.771)(p<0.001) while the
overall survival (OS) did not differ (p=0.097).
conclusion: Hypoxic stress rerated adaptation - highrighted by cArx 
€xpression - resurts in
cellular quiescence in HRS-ceIs potentialy contributing to the short term fairure of the
standard chemotherapy in cH L.
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lntroduction
classical Hodgkin's rymphoma {cHL) is a marignant rymphatic neoprasia of B_ceI origin
characterized by unique cellular changes including the generation of highly atypical
neoplastic proliferation surrounded by a variable extent of reactive elements (1). The
mononucrear Hodgkin- and murtinucreated Reed-sternberg cers represent a morphorogicar
spectrum of the aborted B-cell maturation also referred as HRS-cells (Z). The genomic
features and related phenotypic changes of the neoplastic compartment had been largely
This article is protected by copyright. All rights reserved
uncovered (3, 4), Despite the generally favourable outcome, cHL is complicated with
therapy resistance or disease progression in 25-30% of the patients (5).
classicar HL is frequentry accompanied by variabre amounts of focar necrosis and stromar
reaction' partia'y appearing as a consequence of regionar perfusion defects especiary in theprogressive forms of the disease with nodurar screrosis or rymphocyte depletion (syntitiar
variant) morphorogy (6, 7) simirar to many other marignancies, hypoperfusion and rerated
metabolic disbalance may significantly jnfluence the growth characteristics and the
biorogicar responsiveness of neoprastic HRs-cers (g). Hypoxia induces a series of adaptive
changes in neoplastic cells the majority of which fall under the control of some key
regurators' such as hypoxia inducibre factor 1 (HrF-1)(9). The accumuration of HrF-1d was
demonstrated in an 02_tension dependent manner inducing a profound genomic
reprogramming with the invorvement of severar hundreds of genes in both normar and
transformed ce's (10)' one of the key issues of tumor ce, survivar forowing hypoxia is the
ability to neutrarize intracerurar acidosis due to enhanced glucose utirization and ractic acidproduction The HIF-10 dependent upregulation of membrane carbonic anhydrase lX and Xll(CAIX and CAXII) is an important way to eliminate protons and normalize cytosolic pH in
cancer cels (11' 12) cArx and cAxr are a prominent mem bers of the carbonic anhydrase
enzyme famiry cataryzing bicarbonate production and thus enabring intracerurar proton
carboxylation and excretion (13). physiological CAIX and CAXII expression is limited to a
small set of normal cell types of epithelial origin associated with special pH regulatory
function' such as the proxymar tuburi of the nephron or the gastrointestinar mucosa (14).
However, HIF-1 dependent carbonic anhydrases were repeatedly demonstrated to be
abnorma'y overexpressed in cancer cers. Whire conventionar renar ce, cancer and severar
epitheliar cancer types (gastric and rung adenocarcinomas) showed intrinsic cArx positivity
many other neoplastic tissues and especially especially non_epithelial cancers (including
glioblastoma) expressed CAIX and/or CAX in a hypoxia dependent fashion (15,16,171.
Based on several studies a strong prognostic significance of CAIX in different types of cancer(e.9. breast, head and neck, stomach, liver, pancreas, colorectal carcinomas) was suggested(18).
Information about CAIX or CAXII in human lymphatic tissues is surprisingly limited to date.
Speculations on the potential influence of hypoxia on the biology of cHL were released
earlier based on experimental Hodgkin lymphoma model studies (g, 19) and an increased
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Materials and Methods
Somple selection
Diagnostic sampres from g1 patients with crassicar Hodgkin's rymphoma identified between
1999 and 2015 were reviewed from the archive of the Department of pathology, University
of Debrecen. Ethjcal approval was provided by the national Scientific Ethical Council (no.
60355-2016/EKU). Historogicar diagnosis of cHL was stated according to the current wHo
classification (1) The cohort consisted of cases with various subtypes incruding 51 nodurar
sclerosis (NS),20 mixed cellularity (Mc), 6 lymphocyte rich (LR), 4 lymphocyte depletion (LD)
morphology Additionar (fo,ow up) biopsy materiar was avairabre in r.5 cases ofthe same
cohort
clinicardata were co'ected and disease outcome was determined for a forow up period of
72 months after diagnosis. Treatment of the patients followed the actual jnternational
recommendations 
- the standard doxorubicin, bleomycin, vinblastine and dacarbazine
(ABVD) combination chemotherapy t radiotherapy 
- with intensification and/or autologous
stem cerr transprantation in case of fairure of response or progression. overa, survivar (os)
and progression free survjval (pFS) was calculated for each case in months, based on
electronic patients records
lmmunohistochemistry
Representative rymph node biopsy sampres were evaruated for morphorogicar signs of focar
tissue necrosis fo'owing H&E staining, core needre biopsy sampres were were not incruded
lmm unohistochemistry was done on serjal sections using the rabbit polyclonal antibody
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CAIX activity could be more specifically measured in cHL samples (20). ln agreement with
these observations hypoxia related dynamic upregulation of CAIX in cultivated B-cell
lineages was reported more recentry (21). However, crinicaraspects were not addressed so
far and currently little is known about the role of adaptive cellular response in the
development and outcome of cHL. ln the present paper data are provided demonstrating
the highry serective expression of cArX but not cAx, in the neoprastic compartment of cHL
in a significant number of cases, also reflecting regional differences within the same
lymphoma tissue. We propose that CAIX related functional changes indicate to a special
outfit of the invorved neoprastrc cers potentiary requiring a different anti-cancer strategy.
crones NBloo-417 (Novus Biorogicars, Littreton, co; finar dirution 1:2ooo) for cArx and pA5-
52608 (Thermo-Fisher scientific, Rockford, rL) for cAXr. cD30 antigen was demonstrated by
the antibody crone Ber-H2 (Dako-Agirent, Gropsrup, Danemark) and EBV-rerated LMp-1
protein by the antibody clone CS1_4 (Dako_Agilent). Specific antibody binding was
hjghlighted using the EnVision Flex HRp/DAB+ chromogen detection system (Dako_Agilent)
following antigen retrieval at pH 9,0 as usual, Reactive/uninvolved lymph node samples were
used as negative controls which never presented with any CAIX or CAXII specific signals.
Kidney tissue sampres with renal ce, cancer involvement were used as positive contror
staining where normal and neoplastic cells of tubular origin showed strong membrane
positivity for CAIX and Xll as expected.
Cell proliferation in individual CAIX+ cells was rated following dual IHC reaction for CAIX and
Ki-67 in allcases showing a positive reaction as folows. The nucrear Ki_67 protein was
speclfically labeled with the antibody clone Mjbl (Dako_Agilent; dilution 1:200) and
detected by the EnVision Frex HR'/DAB+ (brown coror) procedure. This was forowed by a
second incubation with the CAtX binding prlmary antibody (see above) that was detected by
the Flex HRP system using the violet Vlp chromogen (Vector Laboratories, Burlingame, CA)
as a substrate. This setting clearly differentiated the Ki67 related brown nuclear staining and
the CAIX specific violet cell membrane staining within the same cells by light microscopy.
Methyl-green solution (vector Laboratories) was used to counterstain unlabeled cell nuclei
for tissue orientation
Data evdludtion
cAlx positive srides were digitarized using the pannoramic digitar sride scanner device
(3DHistech, Budapest, Hungary) and were further analyzed by the pannoramic viewer
software on the screen. HRS cells with and without membrane bound CAIX or CAXII
expression were counted based on the cell size and morphology. Sljdes with more than 10
immunostained HRS cells were defined as unambigous positive. Non_HRS positivity of the
microenvironment was separatery documented, however, quantjfication was not enabred.
For the evaruation of the duar-rHc stained sampres up to 3oo HR5 cers (depending on their
total mass) with or without cArx positivity were considered from different areas of the same
slide. Sections containjng less than 3O representative CAIX+ cells were not considered.
Nuclear Ki-67-positivity within the CAIX_positive and negative HRS_cell fraction was
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determined and the relative frequency of Ki-67 expressing cells for both groups was
statisticar anarysis incruding the Fisher's exact test and the Kapran-Mayer survivar anarysis
was performed using the IBM SPSS Statistics Version 24 software (lBM Analytics).
calculated
Results
CAIX dnd CAXI| immunostoining pottern in cHL
seriar sections with definitive cHL invorvement were evaruated for both cArx and cAx,
im munopositivity' We observed a rimited, but highry serective positive membrane reaction
on individual cells with typical HRS morphology when CAIX specific antibody was applied
(Figure 14) rn contrast, cAx, immunostaining resurted in more indefinite positive areas
consisted mostly of stromal and immune cell types sometimes also including HRS-cells.
(Figure 18) Arthough both cArxand cAx, rabering refrected focar areasofthe neoprastic
proliferation, only cAlx proved to be selective to highlight clusters of HRs-cells within
masses of non-rabering atypicar ce[s (Figure 1c and D). on the other hand, the distinction
between neoprastic HRs cers and the reactive infirtrate of the microenvironment seemed to
be impossible for most of the CAXII immunostained cases.
lnitial lymph node samples from 81 patients (male to female ratio was 40:41) with the
histologicar diagnosis of cHL were evaruated for characteristics of cArx enzyme expression.
cAlx immunopositivity presented with a crear membrane reaction in 39/Sl sampres (4g.1%)
(Table 1). cArx+ HRS cels were generaly rocated in sma| dyscohesive crusters but isorated
singre ce's courd arso be frequentry found. cArx positivity ranged from scattered isorated
HRS-cerrs through severar sma, crusters to rarge sheats of cers with atypicar morphology and
almost uniform strong immunopositivity (up to 80.o%). rn contrast, cels not equivarent wrth
HRS-morphology were generally not marked the same way, Small foci of stromal cells
surrounding strongly positive HRs cells with a weak and indefinite staining were only
occasionally present (2/81 samples, 2.5%).
The laberring pattern was different for cAX, where onry 1g/77 evaruated sampres (23.4%)
displayed distinct membrane HRS-cell positivity. tn addition, stromal and immune cell
reaction could be demonstrated in 50/77 cases (64.9%) which was associated with the
CAXII+ neoplastic compartment but more frequently occured independently due to ac vity
of fibrosis and chronic inflammatory infiltrate.
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CAIX, CAXII ond tissue necrosis in cHL subtypes
As expected, we found a clear morphological relation between the appearance of tissue
necrosis primarily stated in HE_stained slides and the CAIX expressing neoplastic
compartment (Tabre 1') crassicar necrotic foci presented with a centrar amorphous mass
surrounded by several layers of CAIX_posjtive HRS cells demonstrated by
imm unoh istochem istry (Fjgure 2). This repeatedly indicated a direct relation between
sublethal hypoxic damage and cArx upreguration in the marginar zone rining necrotic foci.
CAIX+ was present ln the great majority (18/21) of the samples featured with necrosis(85 7%) However' cArx expression frequentry occured in the absence of crear necrotic
morphology. While unambigous signs of necrosis could be identified in only 2L/87 (25.9%),
CAIX positivity appeared in 39/81 (48.1%) of the samples. CAIX posativity was followed by
necrosis jn onty t8/39 samptes (46.2%) (p<O.OOO1)(Ta bte 1.).
CAIX expression and necrosis were both found to be strongly dependent on the histological
subtype of Hodgkin's rymphoma (Tabre 2). A, four LD cases (100.0%) featured with massive
geographical necrosis and large areas of CAIX+ neoplastic cells. While2g/51 (5G.9%) ofthe
NS cases presented with variable amounts of CAIX expression only 5/20(25,0%) of theN4C
subgroup and a single case of the LR subgroup 11/6, L6.7%)showed CAIX expression.
Differences between historogicar subentities were not that striking when cAX, expression
was tested, except the strong correlation of CAXII with the LD subgro up (4/4, fOO%) lfade
2.).
Cell proliferation ond CAIX expression in HRS_cells
ln order to evaruate the generar functionar status of cArx-expressing HR5 cers we appried
the Ki67 ce',proriferation marker in a doubre rHc setting. HRs-cers were identified on digitar
slides based on their morphology following methyl-green counterstaining. Cells with clear
membrane lHc staining in violet (VlP) were declared as cAlX+ while brown nuclear staining(DAB) referred to Ki67 positivity (Figure 3). Forowing the doubre rHc evaruation in 26
samples applicable (more than 3O HRs_cell available for the analysis) we stated that the
overall Ki67 positivjty (reflecting proliferation capacity) in cAlx+ cells was significantly lower,
than that of the CAIX negative tumor cell compartment. The range of Ki67 positivity
extended between 0.3_51.4% (mean 29.721 13.07) for the CAIX+ and between 51.2_92.0%(mean 69.38r 10.79) for the CAIX negative HRS-cell population (p<0.001) (Figure 4,).
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CAIX ond CAXtt stotus in rebiopsy sdmples
L5 out of the g1 cases included in our evaluation had accessible rebiopsy samples taken due
to therapy failure or recurrance. 13/15 cases belonged to the CAIX expressing cHLs (86.6%).
CAIX immunostaining in these samples presented a special dinamics and was slightly
different from the initiar status' Five rebiopsy sampres (33.3%) changed to negative during
the course of the treatment while the rest of CAIX+ cases also showed a reduced frequency
of CAIX positjve cells in the follow up samples, Ontheotherhand,noneofthenegative
samples converted to positive and significant increase in cArX expression was arso never
detected jn the follow-up series.
CAXIlstaining revealed similar results comparing primary and follow_up lymph node
biopsjes. HRS-cell positivity remained unchanged in 1Ol15 rebiopsy samptes (66.6%) while
turned to negative following jnitial CAX positivity in 5/1S samples (33.3%).
Clinical impact of CAIX ond CAXII expression in cHL
clinical data for 72 months total time period were collected and evaluated for the influence
of necrosis as well as CAIX and CAXII immunopositivity observed in the primary biopsy
sample on generar survivar for a, avairabre cases. The rongest survivar measured was 13g
months from the injtial diagnosis. The overall survival {OS) rate was 0.823 and the
progression free survival (pFS) was 0.504 for the total study population (n=g1), both results
reflecting the current clinjcal standards.
Accordidng to the Kapran-Meier curves and the Manter-cox statisticar anarysis the presence
or absence of necrosis in cHL did not influence the overall survival (0.812 vs 0,833, p=0.469)
and despite a visible mild difference in the pFS, cases featuring tissue necrosis did not
perform statistically worse compared to the non_necrotic cases (0.j.9 vs 0.579, p=9.145, no,
significant) (Figure 5A-B). The centrarized wircoxon (Bresrow) test considering the outcome
and the duration of the follow up revealed the scores O .724 and O.464,respectively.
rnterestingry' a more striking difference was found in reration to cArx expression (Figure 5c-
D) Whire the os differed onry minimary between the cArx-negative and cArx-positive
groups (0,934 vs 0.699, p=9,q97,,1.1istically not significant), pFS proved to be highly
different depending on the CAIX status. Our comparison reflected a statistically highly
significant ronger cumurative progression free survivar in the cArx- (0.771) compared to the
CAIX+ cases (0 19) (p<o.oo1)(Figure 5C-D). The Bresrow-scores were 2.032 for os and 12.162
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for PFS rn contrast' o5 and pFs did not significantry differ between the cAX, negative and
positive rymphomas (p=0 301 and p=0.524, respectivery) in the 77 cases evaruated (Bresrow-
scores were L.977 and 0.649, respectively)(Figure 5E_F).
The positive predictive value (PPV) for an initial treatment failure proved to be 0.76 in case
of CAIX positivity while the negative predictive value (NpV) was O.E6 for lack of progression
in the absence of CAIX expression determined in the initial biopsy sample (p<O.OO3). As
expected PpV and NpV for the CAXII was generally weak (statistically not different, no
predictive va lue),
Discussion
The dynamic overexpression of carbonic anhydrases seems to be an important adaptive
feature due to hypoperfusron rerated tissue hypoxra in serected cancers. The specific rore of
cell membrane bound cArx and cAx, to neutrarize intracerurar acidosis in neoprastic cers
was established in in vitro and in vivo models including knock-down animal model
experiments (22) cArX has been investigated historogicary in a series of cancers and was
found to be associated with aggressive phenotype and/or unfavourable prognosis (1g,23).
considerabry ress information is avairabre for cAX, expression at the historogicar rever.
The potentiar rore of hypoxia in the evorution and progression of cHL was not in the focus of
extended crinicar or morecurar investigations. Hypoxia rerated pathways were not reported
to be genera'y activated in HR5 cers by gene expression studies (4) or epigenetic profiring
(24, 2s).
Here we demonstrated, that further to hypoxic necrosis, an even more significant fraction of
classicar Hodgkin's rymphoma is characterized by focar expression of cArx and cAXr. cArx
IHC showed a strong membrane reaction that proved to be virtuary serective for HRS cers
with only minimal and indefinite IHC staining in bystanding cells in, usually in close proximity
with the strong HRs-cerr reaction. Activated rarge mononucrear tumor cers occasionaly seen
as CAIX positive were interpreted as ,,precursor HRS-cells,, sharing the pathobiology of the
classicar ce'type rncontrast,cAx,rHcraberedaseriesofadditionar 
ce, typesfurtherto
the neoprastic compartment rn our interpretation the cAx, rabering pattern was consistent
with the topography of hypoxic stress generary affecting the comprex tissue composition of
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cHL, including inflammatory and regenerative components. Thus, CAXII labeling did not
appear to serectivery refrect functionarchanges at the individuar cancer ce rever and
seemed to be of rimited utirity to present and interpret the extent of hypoxic adaptation in
histological conditions.
ln contrast to CAXllthe association between CAIX expression and spontaneous necrosis
could be crearry estabrished by histology in untreated primary cHL biopsies. HR5 celrs with
cAlx positivity apparentry formed a we, defined compartment surrounding morphorogicary
recognizable necrotic foci. Moreover, CAIX expressing HRS_cells could be observed in the
great majority (85.7%) of the samples presenting with necrosis by conventional H&E
staining, indicatlng to a close relation between hypoxic damage and CAIX expression. In
reverse, more than half of the samples with CAIX+ compartment did not present with
morphologicar srgns of necrosis. According to this observation focar adaptive changes
induced by non-rethar hypoxic stress may resurt in the serective upreguration of cArx in HRs_
cells and adaptive cArx expression generary occurs prior massive ce, demage in HRs-cers.
On the contrary, expression of isoenzyme CAXII_ supposed to be regulated by the hypoxia
pathway in a similar way 
- 
could be demonstrated in neoplastic HRs_cells in the minority
(23.4%) of the evaluated cases together with the labeling of further non-neoplastic cell
types (fibrobrasts, histiocytes and other immune cers) associated with tissue reparation.
Despite the rimited number of cases refrecting different historogicar subgroups in our cohort
we found basic differences regarding hypoxia rerated features. Frequent occurrance of
necrosis and even more frequent CAIX expression in LD and in NS indicate to general
adaptive and regressive capabirities in these subtypes (in 1oo.o% and 56.9% of the cases,
respectively). rnterestingry, aI four cases of rymphocyte depreted cHL presented with areas
of necrosis and strong membrane cArx expression as we, as cAx, in up to go% of the HRs-
cells in each sampre The LD form presents in the form of a sarcoma rike sorid tumor with the
most unfavourable behaviour among cHL subtypes. lndeed, three out ofthe four patients
with LD cHL and cArx/cAx expression died of disease progression within 14 months after
diagnosis. ln contrast, the general lack of necrosis and the low frequency CA expression in
LR and MC subtypes of cHL suggest that hypoperfusion and hypoxia-related reprogramming
is less relevant in the course of these histological forms.
lmportantly, cancer cells suffering from hypoxia and acidosis tend to aquire regressive
features also shared by cancer stem cells (7, 26, 27). The functional analysis of the tumor
cell compartment could be done in the present study using a CAIX/K|-67 double IHC
approach, The Ki-G7 nuclear protein is a key factor of cell cycle progression (28, 29), which
can be demonstrated with high affinity by the antibody crone Mib-1 (30). The Ki-67 rabering
index is widely used to estimate the proliferative capacity and as such it is an established
prognostjc factor in different malignant conditions (31, 32, 33) including lymphoid
neoplasias (34) Earlier data reported a generally high cell proliferation activity in HRs_cells
withover90%cell cycle activity (35) andKi-67 jndices between 57%and gO% 136,371.
Detailed analysjs by Tzankov et al (35) suggested profound cell cycle regulatory defects
behind these high overarr ratios cAlx/Ki67 doubre imm unohistochem istry enabred us to
djfferentiate and demonstrate adaptation related cell cycle activity in HRs-cells for the first
time unfortunaterv, a duar rHc settingfor CMt/Ki67 faired due to the high number of
cAx'+ bystanding ce's and unsatisfactory identification of the ce, composition required for
the analysis. The cell proliferation of CAIX expressing neoplastlc cells proved to be strongly
repressesed lmean 29.72! 13.07) compared to the CAIX negative compartment (mean
69 38i 10.79) of the same biopsv sampre. Despite the generaly high proriferation rate,
CAIX-positivity was associated with suppressed cell cycle activity in all evaluated samples,
irrespective of the historogicar subtype. ceIurar quiescence in the positive HRs_ce
compartment is in good agreement with the limited actuar energy suppry of the immediate
tissue environment. This observation further supports the beneficial effect of CAIX
Tissue perfusion is generally more likely to be challanged in aggressive forms of cHL. The
functional changes due to hypoxic adaptauon therefore may have major clinical impact onprogression and therapeutic response in cHL, As a very first attempt we evaluated the
clinicar course rerated to tissue necrosis and adaptation driven cArx and cAx, upreguratron
in 81cHL cases. While necrosis had only little effect (p=0.14G) and CAXII dld not show any
influence (p=0.s24) on therapy response (pFs), cases with cArx expression had a highry
distinct (p<O.OO1) unfavourable response to the frontline standard therapy. This effect
remained still mlnimally visible when the overall survival rates were compared (p=0.097).
Thus' cArX expression in cHL courd be associated with the fairure of the initiar treatment
expression in hypoxia_related adaptatjon.
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according to the standard therapy (ABVD)even in a univariate setting. Both the positive
predictive varue (ppV) and the negative predictive varue (Npv) of cArx expression indicated
to the strongry erevated rikeryhood of fairure/progression after the initiar chemotherapy
176.2 and 65.9%, respectively).
Based on these first observations hypoxia rerated adaptive mechanisms seem to have an
important role in the complex biology of cHL. Especially CA|X was found promising to
selectively highlight hypoxic cellular demage in the neoplastic compartment. cAlx
imm unohistochemistry of the primary biopsy specimen may help to predict initial therapy
response and to select high-risk patients right at the diagnosis of classical Hodgkin
lymphoma.
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Table and Figure legends
Tabre l' Expression of cArx and cAX' in HRS-cers in reration to tissue necrosis determined
by historogy in cHL lymph node biopsies at diagnosis (n=81). The statisticary significantpositive association between cArx-positivity and necrotic foci was estabrished by Fisher,s
exact test (p<0 001, asterix). No correration between cAxr-expression and necroses courd
be stated (p=0.3S)
Table 2. Occurrance of necrosis, CAIX+ and CAXII+ HRS-cells according to histological
subtypes in cHL. CAIX-expression was most frequently observed in LO and NS subtypes. All
samples ofthe LD group featured both cAlx+ and cAX + HRS_cells l4/4,loo%),this
difference was statistica'y significant compared to any of the other historogicar subgroups(p<0 001, independent-sa mpres t-test). (NS, nodurar screrosis; Mc, mixed ceIurarity; LR,lym phocyte-rich; LD, lymphocyte depleted)
Thjs article is protected by copyright. All rights reserved.
Figure 1' Membrane expression of cArX (A) and cAX' (B) in HRS cers in crassicar Hodgkins
lymphoma. whire cArX immunostaining proved to be virtualy serective for the HRs ce,
morphology spectrum, cAXll positivity was frequentry observed in immune cers including
histiocytes and stromal fibroblasts (x4O magnification, scale bar represents 50gm).
Figure 2. Double immunohistochemistry highlighting HRS-cells by CD30 (DAB-chromogen,
brown) and the CAIX specific staining (Vlp_chromogen, violet) in different regions of a
representative samples. Scattered CD30+ cells are presented lacking CAIX_positivity in panel
A (arrowheads). A cluster of CD3O+/CA|X+ double immunopositive HRS_cells is indicated by
arrows, surrounded by CD30+ HRS_cells lacking CAIX expression (arrowheads) in panel B(both x20 magnification, scare bar 100 Bm). cD3o+/cArx+ doubre posrtave cers (arrows)
typically arranged as a well defined zone demarcating a focal necrotic core (panel C)(x1O
magnification, scale bar 200 pm).
magnification)
Figure 4. Ki-67 labeling index determined separately in CAIX+ and CA|X_ HRS cell
compartments within the same untreated cHL biopsy samples featuring CAIX expressing
clusters and applicable for dual IHC analysis (n=26). Ki67 labeling index proved to be
signifjcantly lower in CAIX+ HRS-cells (p<O.OO1) indicating to adaptatjon related cell-cycle
arrest
This article is protected by copyright. All rights reserved
Figure 3. Double immunoh istochemistry highlighting nuclear Ki_67 staining (DAB_brown) and
cArx specific staining (Vrp-vioret) from two representative sampre fierds (A and B). Note the
missing nucrear staining in cArx+ rarge HRS cels (arrows) compared to the intense Ki-67
labeling in some of the surrounding large cells lacking CAIX staining (arrowheads) (x100
Figure 5. Kaplan-Meier curves reflecting 72 months overall survival (left column) andprogression free survrvar (right corumn) rerated to the presence of necrosis (A and B), cArX(c and D) as we' as cAx'expression (E and F) in crassrcar Hodgkin rymphoma. statisticary
highly significant difference in pFS was calculated in favour of the CA lX- (0.77})compared
to CAIX+ (0.19) group (p<o.OO1)(D).
Table 1' Expression of cArx and cAX, in HR'-cers in reration to tissue necrosis determinedby historogy in cHL rymph node biopsies at di.gnoris 1n=ai1. ihe itatisticarty signiticantpositive association between CAtX-positivity a;d n"crotic fo.i *a, 
"stablished by Fisher,sexact test (p<0 001, asterix). No correration between cAXr-exprl-rrron 
"na 
necrosis courd bestated (p=0.35)
cAlx*
HRs (%)
cAxil.
HRs (%)
necrosis (%)
pos
L8 (22.2)*
3 (3.7)
e (11.7)
72 (1s.6)
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s (11.7)
47 (61.0)
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3s (48.1)
42 (s1.e)
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s9 (76.6)
2t (2s.9) 60 (74.1) 8t (100.0)
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21, (2s.9)
39 (48.1)
I;ifffi :ff :;:r::l;:J:;:;'^ x+ and cAxil+ HRs'ceils accordins to historosical
sam p r e s or t h el. o r. * ?".i,. rI:; IfiI'.HTI f ;'JJ:il ;0, anarrr s s uiw o e s. a r rdifference was statistica'y sienificant compared to any or tr'e oit 
",. 
nrrtorogicar subgroups(p<0.001, independent-samples t_test). 1ruS, noOutar scterori,]ra, ,,r"0 .",,ularity; LR,lym phocyte-rich; LD, lymphocyte depleted)
NS
MC
LR
TD
necrosis (%) CA|X'
t4/s1(27.s)
3/20 (1s.0)
1/6 (16.7)
3/4 (7s.0)
HRS (%) cAxlt. HRsl%)
70/49 (20.4)
3/18 (16.7)
t/6 (16.7)
4/4 (100.0)*
18/77 (23.4)
2s/s1. (s6.s)
s/20 (2s.0)
1/6 (16.7)
4/4 (100.0)*
total 21/87 (2s.9) 3e (48.1)
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Figure 1' Membrane expression of cArx (A) and cAx, (B) in HRS cerrs in crassicar Hodgkinslymphoma while cAlX immunostaining proved to be virtuarI setective ror ttre Hns cettmorphology spectrum, cAX, positivity was frequentry observed iri-immune cers incrudinghistiocytes and stromatfibrobtasts (x40 magnificatio;, ;;;; ;.; ;r"rents soIm).
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